ONY Biotech
Randy Burkard joined ONY Biotech as a Board Director and shareholder in October 2013 and assumed the role of President and CEO in December 2016. He brings more than 30 years of business experience in various industries including general management, sales, marketing and operations, to the ONY Biotech team.
Prior to joining the team, Burkard was President of Science Kit & Boreal Laboratories. He has held various positions with RR Donnelley, The Chas. Levy Company, Accenture, and General Electric.
In his role at ONY Biotech, Burkard provides overall company direction, facilitating teamwork and innovation and being a constant advocate for the patients being treated with Infasurf® and the hospitals who care for them.
This person is not in any offices
ONY Biotech
A small, privately-held, and family-focused neonatology pharmaceutical company, ONY Biotech is a leader in the creation of critically important products for the treatment of premature infants. They innovate with a singular purpose: to improve outcomes for premature babies and their families.